The t (15; 17) translocation that generates PML-RARα fusion mRNA is detected in as many as 90% of APL patients and has become the definitive marker for the disease (Dos Santos et al., 2013; Zhang et al., 2021). Here, PML is linked to acute promyelocytic leukemia.